CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
88 hedge funds and large institutions have $1.77B invested in China Biologic Products Holdings, Inc. in 2019 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% less call options, than puts
Call options by funds: $22.8M | Put options by funds: $32.2M
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
88
Holding in Top 10
4
Calls
$22.8M
Puts
$32.2M
Top Buyers
| 1 | +$96.4M | |
| 2 | +$24.6M | |
| 3 | +$19.8M | |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$9.56M |
| 5 |
MCP
Maso Capital Partners
Hong Kong
|
+$8.28M |
Top Sellers
| 1 | -$32.7M | |
| 2 | -$27.4M | |
| 3 | -$26.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.3M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$11.4M |